BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 25672784)

  • 1. Drip and ship thrombolytic therapy for acute ischemic stroke: use, temporal trends, and outcomes.
    Sheth KN; Smith EE; Grau-Sepulveda MV; Kleindorfer D; Fonarow GC; Schwamm LH
    Stroke; 2015 Mar; 46(3):732-9. PubMed ID: 25672784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of the Drip-and-Ship Paradigm for Patients with Acute Ischemic Stroke in South Korea.
    Park MS; Lee JS; Park TH; Cho YJ; Hong KS; Park JM; Kang K; Lee KB; Kim JG; Lee SJ; Lee J; Choi KH; Kim JT; Cho KH; Oh MS; Yu KH; Lee BC; Cha JK; Kim DH; Nah HW; Lee J; Kim DE; Ryu WS; Kim BJ; Han MK; Bae HJ; Song SK; Choi JC
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2678-2687. PubMed ID: 27480820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drip-and-Ship Thrombolytic Therapy for Acute Ischemic Stroke.
    Deguchi I; Mizuno S; Kohyama S; Tanahashi N; Takao M
    J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):61-67. PubMed ID: 28867523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S; Zand R; Al-Wafai A; Wahba MN; Giraldo EA
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):969-71. PubMed ID: 22306381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drip-and-ship thrombolytic treatment paradigm among acute ischemic stroke patients in the United States.
    Tekle WG; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    Stroke; 2012 Jul; 43(7):1971-4. PubMed ID: 22669407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes Among Patients With Ischemic Stroke Treated With Intravenous tPA (Tissue-Type Plasminogen Activator) via Telemedicine.
    Wysocki NA; Bambhroliya A; Ankrom C; Vahidy F; Astudillo C; Trevino A; Malazarte R; Cossey TC; Jagolino-Cole A; Savitz S; Wu TC; Sharrief A
    Stroke; 2019 Apr; 50(4):895-900. PubMed ID: 30852962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of the new ICD-9-CM code for "drip-and-ship" thrombolytic treatment in patients with ischemic stroke.
    Tonarelli SB; Tibbs M; Vazquez G; Lakshminarayan K; Rodriguez GJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):121-3. PubMed ID: 20851622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the drip-and-ship approach to delivering thrombolysis for acute ischemic stroke safe?
    Martin-Schild S; Morales MM; Khaja AM; Barreto AD; Hallevi H; Abraham A; Sline MR; Jones E; Grotta JC; Savitz SI
    J Emerg Med; 2011 Aug; 41(2):135-41. PubMed ID: 19272734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of thrombolytic therapy in acute ischemic stroke: mothership, drip-and-ship, and ship-and-drip paradigms.
    Kijpaisalratana N; Chutinet A; Akarathanawat W; Vongvasinkul P; Suwanwela NC
    BMC Neurol; 2020 Feb; 20(1):45. PubMed ID: 32013906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after tissue plasminogen activator administration under the drip and ship paradigm may differ according to the regional stroke care system.
    Cha JK; Nah HW; Kang MJ; Kim DH; Park HS; Kim SB; Jeong EH; Huh JT
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):160-3. PubMed ID: 24157090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke.
    Gerschenfeld G; Muresan IP; Blanc R; Obadia M; Abrivard M; Piotin M; Alamowitch S
    JAMA Neurol; 2017 May; 74(5):549-556. PubMed ID: 28319240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to guidelines by emergency medical services during transport of stroke patients receiving intravenous thrombolytic infusion.
    Asaithambi G; Chaudhry SA; Hassan AE; Rodriguez GJ; Suri MF; Qureshi AI
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e42-5. PubMed ID: 22572162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke mimics under the drip-and-ship paradigm.
    Mehta S; Vora N; Edgell RC; Allam H; Alawi A; Koehne J; Kumar A; Feen E; Cruz-Flores S; Alshekhlee A
    J Stroke Cerebrovasc Dis; 2014; 23(5):844-9. PubMed ID: 23954600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or telephone before transfer to a regional stroke center is feasible and safe.
    Pervez MA; Silva G; Masrur S; Betensky RA; Furie KL; Hidalgo R; Lima F; Rosenthal ES; Rost N; Viswanathan A; Schwamm LH
    Stroke; 2010 Jan; 41(1):e18-24. PubMed ID: 19910552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative.
    Fonarow GC; Zhao X; Smith EE; Saver JL; Reeves MJ; Bhatt DL; Xian Y; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2014 Apr 23-30; 311(16):1632-40. PubMed ID: 24756513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standard-dose intravenous tissue-type plasminogen activator for stroke is better than low doses.
    Liao X; Wang Y; Pan Y; Wang C; Zhao X; Wang DZ; Wang C; Liu L; Wang Y;
    Stroke; 2014 Aug; 45(8):2354-8. PubMed ID: 25013020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke.
    Saver JL; Fonarow GC; Smith EE; Reeves MJ; Grau-Sepulveda MV; Pan W; Olson DM; Hernandez AF; Peterson ED; Schwamm LH
    JAMA; 2013 Jun; 309(23):2480-8. PubMed ID: 23780461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator.
    Xian Y; Liang L; Smith EE; Schwamm LH; Reeves MJ; Olson DM; Hernandez AF; Fonarow GC; Peterson ED
    JAMA; 2012 Jun; 307(24):2600-8. PubMed ID: 22735429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Selection for Drip and Ship Thrombolysis in Acute Ischemic Stroke.
    Lyerly MJ; Albright KC; Boehme AK; Shahripour RB; Donnelly JP; Houston JT; Rawal PV; Kapoor N; Alvi M; Sisson A; Alexandrov AW; Alexandrov AV
    South Med J; 2015 Jul; 108(7):393-8. PubMed ID: 26192934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.